217 related articles for article (PubMed ID: 23920484)
1. Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem.
Hiraiwa Y; Morinaka A; Fukushima T; Kudo T
Bioorg Med Chem; 2013 Sep; 21(18):5841-50. PubMed ID: 23920484
[TBL] [Abstract][Full Text] [Related]
2. Metallo-beta-lactamase inhibitory activity of phthalic acid derivatives.
Hiraiwa Y; Morinaka A; Fukushima T; Kudo T
Bioorg Med Chem Lett; 2009 Sep; 19(17):5162-5. PubMed ID: 19632114
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystallographic analysis of IMP-1 metallo-β-lactamase complexed with a 3-aminophthalic acid derivative, structure-based drug design, and synthesis of 3,6-disubstituted phthalic acid derivative inhibitors.
Hiraiwa Y; Saito J; Watanabe T; Yamada M; Morinaka A; Fukushima T; Kudo T
Bioorg Med Chem Lett; 2014 Oct; 24(20):4891-4. PubMed ID: 25246278
[TBL] [Abstract][Full Text] [Related]
4. In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.
Ishii Y; Eto M; Mano Y; Tateda K; Yamaguchi K
Antimicrob Agents Chemother; 2010 Sep; 54(9):3625-9. PubMed ID: 20606062
[TBL] [Abstract][Full Text] [Related]
5. IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
Tada T; Nhung PH; Miyoshi-Akiyama T; Shimada K; Phuong DM; Anh NQ; Ohmagari N; Kirikae T
Antimicrob Agents Chemother; 2015 Nov; 59(11):7090-3. PubMed ID: 26282421
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase.
Ho SE; Subramaniam G; Palasubramaniam S; Navaratnam P
Antimicrob Agents Chemother; 2002 Oct; 46(10):3286-7. PubMed ID: 12234862
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases.
Nagano R; Adachi Y; Imamura H; Yamada K; Hashizume T; Morishima H
Antimicrob Agents Chemother; 1999 Oct; 43(10):2497-503. PubMed ID: 10508031
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1beta-methylcarbapenem, against transferable IMP-1 metallo-beta-lactamase producers.
Nagano R; Adachi Y; Hashizume T; Morishima H
J Antimicrob Chemother; 2000 Mar; 45(3):271-6. PubMed ID: 10702544
[TBL] [Abstract][Full Text] [Related]
9. Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems combined with EDTA against Pseudomonas aeruginosa strains producing VIM-metallo beta-lactamases.
Bedenić B; Vranes J; Sviben M; Beader N; Kalenić S
Chemotherapy; 2008; 54(3):188-93. PubMed ID: 18560225
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
11. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
Ohlasova D; Kmet V; Niks M
Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
[No Abstract] [Full Text] [Related]
12. Effect of sodium mercaptoacetic acid on different antimicrobial disks in the sodium mercaptoacetic acid double disk synergy test for detection of IMP-1 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Japan.
Sakanashi D; Miyazaki N; Kawamoto Y; Ohno T; Yamada A; Koita I; Miyajima S; Suematsu H; Hagihara M; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2019 Jan; 25(1):75-77. PubMed ID: 30100401
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.
Hakimelahi GH; Moosavi-Movahedi AA; Saboury AA; Osetrov V; Khodarahmi GA; Shia KS
Eur J Med Chem; 2005 Apr; 40(4):339-49. PubMed ID: 15804533
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.
Yamada K; Yanagihara K; Kaku N; Harada Y; Migiyama Y; Nagaoka K; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Hasegawa H; Yasuoka A; Kohno S
Int J Antimicrob Agents; 2013 Sep; 42(3):238-43. PubMed ID: 23891525
[TBL] [Abstract][Full Text] [Related]
15. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
Pfennigwerth N; Geis G; Gatermann SG; Kaase M
J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992
[TBL] [Abstract][Full Text] [Related]
16. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
Moloughney JG; D Thomas J; Toney JH
FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.
Arjomandi OK; Hussein WM; Vella P; Yusof Y; Sidjabat HE; Schenk G; McGeary RP
Eur J Med Chem; 2016 May; 114():318-27. PubMed ID: 27017264
[TBL] [Abstract][Full Text] [Related]
18. IMP-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa in a university hospital in the People's Republic of China.
Wang CX; Mi ZH
J Antimicrob Chemother; 2004 Dec; 54(6):1159-60. PubMed ID: 15537691
[No Abstract] [Full Text] [Related]
19. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
[TBL] [Abstract][Full Text] [Related]
20. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa.
Zhao WH; Hu Z; Chen G; Ito R; Hu ZQ
Chemotherapy; 2009; 55(3):168-74. PubMed ID: 19420932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
